Home> Products> rigidity

{ "products": [ { "_id": "68949d4ea0059029dc8c8915", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BENZTETRA 25", "description": "BENZTETRA 25 contains the active ingredient tetrabenazine 25mg, a specialized medication used primarily to manage involuntary movements associated with neurological disorders. Tetrabenazine is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor and works by regulating the levels of neurotransmitters such as dopamine, serotonin, norepinephrine, and histamine in the brain. This correction of chemical imbalances helps reduce excessive and uncontrolled muscle movements. BENZTETRA 25 is especially valuable for patients suffering from movement disorders that significantly impact their daily functioning. It helps improve motor control, thereby enhancing quality of life for those affected. This medication is prescribed mainly to treat chorea—a movement disorder characterized by jerky, irregular, and uncontrollable muscle movements—that is caused by Huntington disease.\n\nWhat is BENZTETRA 25?\nBENZTETRA 25 is a therapeutic tablet containing tetrabenazine 25mg, designed to treat involuntary movements (chorea) linked to Huntington disease. It does not cure Huntington disease nor address cognitive or psychiatric symptoms of the disease but effectively reduces the severity of abnormal movements by altering neurotransmitter activity in the brain.\n\nUses of BENZTETRA 25\n\nTo treat chorea (a movement disorder) that is caused by Huntington disease.\n\nTo control involuntary muscle movements in Huntington’s disease patients.\n\nManagement of other hyperkinetic movement disorders as determined by a healthcare provider (such as tardive dyskinesia or Tourette syndrome in some cases).\n\nTo reduce excessive motor activity caused by abnormal nerve signaling in the brain, improving voluntary muscle control.\n\nSide Effects of BENZTETRA 25\n\nDrowsiness and fatigue, which may affect alertness.\n\nInsomnia or difficulty sleeping.\n\nNausea, vomiting, or abdominal discomfort.\n\nParkinsonism symptoms such as tremors, muscle rigidity, and slowed movements (bradykinesia).\n\nMood alterations including depression, anxiety, and in severe cases, suicidal thoughts.\n\nRare serious reactions like allergic responses, heart rhythm irregularities, or neuroleptic malignant syndrome (characterized by high fever, muscle stiffness).\n\nPrecautions Before Using BENZTETRA 25\n\nInform your doctor if you have a history of depression, suicidal thoughts, or any psychiatric illness.\n\nAvoid use if you have severe liver disease or have recently taken monoamine oxidase inhibitors (MAOIs).\n\nCaution in patients with cardiac issues due to potential QT interval prolongation.\n\nUse with care when driving or operating machinery as BENZTETRA 25 may cause dizziness or drowsiness.\n\nDo not stop the medication suddenly without consulting your healthcare provider, as symptoms might worsen.\n\nRegular monitoring by a healthcare professional is recommended to assess side effects and efficacy.\n\nDrug Interactions: What Drugs Interact with BENZTETRA 25?\n\nMAO inhibitors such as isocarboxazid, phenelzine, selegiline, and others can cause dangerous interactions and should not be used concurrently.\n\nOther drugs that affect serotonin levels, including selective serotonin reuptake inhibitors (SSRIs), may increase the risk of serotonin syndrome.\n\nCaution with other medications known to prolong the QT interval or those affecting dopamine systems.\n\nInteractions with neuroleptics or antipsychotics require close medical supervision due to additive effects on movement and mood.\n\nConclusion\nBENZTETRA 25, containing tetrabenazine 25mg, is a vital medication for managing chorea associated with Huntington disease by modulating neurotransmitter levels in the brain to reduce involuntary movements. While it offers substantial benefits in improving motor control, careful attention to side effects, precautions, and drug interactions is essential for safe and effective use. Always follow the guidance of a healthcare professional when using BENZTETRA 25 to ensure optimal outcomes and safety.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2158, "imageuri": "https://productimages.withfloats.com/actual/68949d54c82f93461bdc841f.png", "tileimageuri": "https://productimages.withfloats.com/tile/68949d54c82f93461bdc841f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-07T12:34:22.411Z", "updatedon": "2025-08-07T12:34:22.411Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benztetra-25/2158", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "tetrabenazine 25mg", "category": "NEUROLOGY RANGE", "tags": [ "tetrabenazine 25mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68723260f860f0528a938842", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AMIPULSIDE CR 400", "description": "AMIPULSIDE CR 400 is a prescription-based, controlled-release formulation of Amisulpride 400 mg, developed to offer sustained therapeutic effects with once-daily dosing. Manufactured to high quality standards, this medication plays a vital role in the management of both acute and chronic schizophrenic disorders. It belongs to the class of atypical antipsychotics and works by regulating the activity of certain neurotransmitters in the brain, primarily dopamine. This helps control symptoms like hallucinations, delusions, disorganized thinking, and social withdrawal associated with schizophrenia.\n\nWhat is AMIPULSIDE CR 400?\nAMIPULSIDE CR 400 contains Amisulpride, a selective dopamine D2/D3 receptor antagonist. It is primarily used in the treatment of schizophrenia, particularly effective in managing both positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy). The controlled-release (CR) formulation allows for steady absorption and action, improving patient compliance and reducing fluctuations in symptom control.\n\nThis medication is designed for the treatment of acute and chronic schizophrenic disorders and is often used as part of a comprehensive psychiatric care plan, including counseling and behavioral therapy.\n\nUses of AMIPULSIDE CR 400\nManagement of acute episodes of schizophrenia\n\nLong-term maintenance therapy for chronic schizophrenic disorders\n\nEffective in treating positive symptoms (e.g., hallucinations, paranoia)\n\nBeneficial in alleviating negative symptoms (e.g., lack of motivation, social withdrawal)\n\nSide Effects of AMIPULSIDE CR 400\nLike all medications, AMIPULSIDE CR 400 may cause side effects in some patients. Common side effects include:\n\nInsomnia or drowsiness\n\nWeight gain\n\nConstipation\n\nAnxiety\n\nIncreased prolactin levels (can lead to breast tenderness or menstrual changes)\n\nTremors or stiffness (extrapyramidal symptoms)\n\nSerious but rare side effects may include:\n\nNeuroleptic malignant syndrome (fever, muscle rigidity, confusion)\n\nIrregular heart rhythms\n\nSeizures\n\nSeek immediate medical help if you experience chest pain, severe dizziness, or signs of an allergic reaction.\n\nPrecautions Before Using AMIPULSIDE CR 400\nBefore starting treatment with AMIPULSIDE CR 400, inform your doctor if:\n\nYou have a history of heart disease or irregular heart rhythms\n\nYou suffer from kidney or liver dysfunction\n\nYou are pregnant, planning pregnancy, or breastfeeding\n\nYou have Parkinson’s disease\n\nYou have low potassium or magnesium levels in your blood\n\nAvoid alcohol and other central nervous system depressants while taking this medication, as they may increase drowsiness or impair alertness.\n\nDrug Interactions\nAmisulpride can interact with a variety of medications, which may enhance or diminish its therapeutic effects or increase the risk of adverse events.\n\nWhat Drugs Interact with AMIPULSIDE CR 400?\nAntiarrhythmic drugs (e.g., quinidine, amiodarone): May increase the risk of heart rhythm abnormalities\n\nCNS depressants (e.g., benzodiazepines, opioids): Increase sedation and respiratory depression risk\n\nLevodopa and dopamine agonists: Can counteract the effect of Amisulpride\n\nSSRIs (e.g., fluoxetine, paroxetine): May increase the plasma levels of Amisulpride\n\nDrugs that prolong QT interval (e.g., erythromycin, haloperidol): May raise the risk of cardiac arrhythmias\n\nDiuretics: May alter electrolyte balance, increasing risk of heart rhythm disturbances\n\nAlways disclose all medications, supplements, or herbal products you are taking to your healthcare provider before starting AMIPULSIDE CR 400.\n\nConclusion\n\nAMIPULSIDE CR 400 (Amisulpride 400 mg CR Tablet) is a clinically effective medication for individuals suffering from schizophrenia, offering reliable symptom control through its controlled-release formulation. Its ability to treat both the acute and chronic phases of the disorder makes it a cornerstone in psychiatric management. Regular monitoring and adherence to prescribed guidelines ensure optimal results and improved quality of life for patients.", "price": 595.0, "discountamount": 179.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2145, "imageuri": "https://productimages.withfloats.com/actual/687232764d22e47aa874e361.png", "tileimageuri": "https://productimages.withfloats.com/tile/687232764d22e47aa874e361.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-12T10:01:04.938Z", "updatedon": "2025-07-12T10:01:04.938Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/amipulside-cr-400/2145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "amisulpride tablet", "category": "NEUROLOGY RANGE", "tags": [ "Amisulpride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e670cc6d2d31770978860", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEFEXOTIME DICLOXA ", "description": "CEFEXOTIME DICLOXA \nCefixime (200mg), Dicloxacillin ER (500mg)\nIntroduction\nCEFEXOTIME DICLOXA is a potent antibiotic combination therapy that includes Cefixime (200mg) and Dicloxacillin ER (500mg). This medication is designed to combat a broad spectrum of bacterial infections, leveraging the synergistic effects of both antibiotics to enhance efficacy.\n\nComposition\n\nCefixime (200mg): A third-generation cephalosporin antibiotic known for its broad-spectrum activity against Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.\nDicloxacillin ER (500mg): An extended-release form of dicloxacillin, a penicillinase-resistant penicillin. It is particularly effective against penicillinase-producing staphylococci and works by inhibiting cell wall synthesis.\nMechanism of Action\n\nCefixime: It binds to penicillin-binding proteins (PBPs) within the bacterial cell wall, disrupting the cross-linking of peptidoglycan chains necessary for cell wall strength and rigidity, resulting in cell lysis.\nDicloxacillin: It similarly binds to PBPs, preventing the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, which is crucial for maintaining cell wall integrity.\nIndications\nCEFEXOTIME DICLOXA is indicated for the treatment of various bacterial infections, including:\n\nRespiratory tract infections (e.g., bronchitis, pneumonia)\nUrinary tract infections (UTIs)\nSkin and soft tissue infections\nOtitis media\nSinusitis\nBone and joint infections\nDosage and Administration\nThe typical dosage for adults is one tablet taken twice daily, with or without food. The duration of treatment depends on the severity and type of infection, usually ranging from 7 to 14 days. It is essential to complete the full course of therapy to prevent the development of antibiotic-resistant bacteria.\n\nSide Effects\nCommon side effects may include:\n\nGastrointestinal disturbances (nausea, vomiting, diarrhea)\nAllergic reactions (rash, itching, anaphylaxis in severe cases)\nPseudomembranous colitis\nHepatic dysfunction (elevated liver enzymes)\nHematologic effects (eosinophilia, neutropenia)\nRenal toxicity (in rare cases)\nPrecautions\n\nAllergy: Patients with a history of allergic reactions to cephalosporins, penicillins, or any other beta-lactam antibiotics should use this medication with caution.\nRenal Impairment: Dose adjustment may be necessary for patients with renal dysfunction.\nPregnancy and Lactation: The safety of this medication in pregnant and breastfeeding women has not been fully established. It should only be used if clearly needed and prescribed by a healthcare provider.\nDrug Interactions\n\nProbenecid: May increase blood levels of Cefixime.\nWarfarin: Concomitant use can enhance anticoagulant effects, increasing the risk of bleeding.\nMethotrexate: Cefixime may reduce renal clearance of methotrexate, increasing its toxicity.\nOral Contraceptives: Antibiotics may reduce the efficacy of oral contraceptives, suggesting the need for additional contraceptive measures.\nConclusion\nCEFEXOTIME DICLOXA, with its combination of Cefixime and Dicloxacillin, provides a robust treatment option for various bacterial infections. Its broad-spectrum efficacy, combined with the extended-release formulation, ensures a potent and convenient antibiotic therapy. As with all antibiotics, it is crucial to use this medication as prescribed and complete the full course to prevent the emergence of resistant bacteria and achieve optimal therapeutic outcomes. Always consult with a healthcare professional before starting any new medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 395.0, "discountamount": 118.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "rare cases", "one tablet", "cell lysis", "full course", "blood levels", "severe cases", "7 to 14 days", "Otitis media", "new medication", "Renal toxicity", "typical dosage", "broad spectrum", "renal clearance", "Concomitant use", "Dose adjustment", "Dicloxacillin ER", "Renal Impairment", "joint infections", "Drug Interactions", "renal dysfunction", "Allergic reactions", "CEFEXOTIME DICLOXA", "cell wall strength", "Oral Contraceptives", "healthcare provider", "breastfeeding women", "Hepatic dysfunction", "Hematologic effects", "synergistic effects", "Common side effects", "cell wall integrity", "peptidoglycan chains", "bacterial cell walls", "extended-release form", "anticoagulant effects", "Gram-negative bacteria", "soft tissue infections", "elevated liver enzymes", "broad-spectrum efficacy", "healthcare professional", "broad-spectrum activity", "peptidoglycan synthesis", "robust treatment option", "Pseudomembranous colitis", "Urinary tract infections", "penicillin-binding proteins", "final transpeptidation step", "Respiratory tract infections", "various bacterial infections", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "antibiotic-resistant bacteria", "other beta-lactam antibiotics", "convenient antibiotic therapy", "bacterial cell wall synthesis", "additional contraceptive measures", "penicillinase-resistant penicillin", "penicillinase-producing staphylococci", "potent antibiotic combination therapy", "third-generation cephalosporin antibiotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1928, "imageuri": "https://productimages.withfloats.com/actual/668e670f4e0af60ab3e5e128.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e670f4e0af60ab3e5e128.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T10:48:44.065Z", "updatedon": "2024-07-10T10:48:44.065Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefexotime-dicloxa-/1928", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEFEXOTIME DICLOXA ", "category": "GENERAL RANGE", "tags": [ "Cefixime and Dicloxacillin tablets Uses in Hindi", "Cefixime+Dicloxacillin er tablets", "", "Cefixime and Dicloxacillin uses", "Cefixime Dicloxacillin and lactic acid bacillus ta", "", "Cefixime + Dicloxacillin and Lactic acid bacillus ", "Cefixime Dicloxacillin mr and lactic acid bacillus", "Cefixime and Dicloxacillin tablets side effects", "Cefixime dicloxacillin tablet uses in tamil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae69aaebebd0900165264", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RASAGAIL 1", "description": "RASAGAIL 1\nRasagail 1.0 \nIntroduction:\n\nRasagail 1.0 embodies the therapeutic efficacy of Rasagiline, a potent monoamine oxidase-B (MAO-B) inhibitor renowned for its role in managing Parkinson's disease. With a dosage strength of 1.0mg, Rasagail 1.0 offers a targeted approach to alleviate symptoms, enhance motor function, and potentially slow disease progression in Parkinson's patients.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 1.0 exerts its primary action by selectively inhibiting MAO-B enzymes, leading to increased dopamine levels within the brain's striatum. This mechanism aids in alleviating motor symptoms and improving overall motor function.\nNeuroprotection:\n\nBeyond symptom relief, Rasagail 1.0 demonstrates neuroprotective properties by reducing oxidative stress, preserving neuronal integrity, and potentially exerting disease-modifying effects in Parkinson's disease.\nImproved Motor Function:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 1.0 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and functional independence.\nFlexible Dosing:\n\nRasagail 1.0 allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, disease severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 1.0 is 1.0mg once daily, administered orally with or without food. Dosage adjustments may be considered based on individual patient response and tolerability.\nTitration and Maintenance:\nTitration of Rasagail 1.0 may occur under medical supervision to achieve optimal therapeutic benefits while minimizing adverse effects. Maintenance doses are typically adjusted as needed to sustain symptom control.\nContinued Monitoring:\nOngoing clinical monitoring of Parkinson's disease symptoms, motor function, and potential side effects is essential during Rasagail 1.0 therapy to ensure treatment efficacy and patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/rasagail-1-0-133623\n", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "role", "food", "brain", "1.0mg", "Order", "EMAIL", "tremors", "patients", "rigidity", "striatum", "Titration", "Parkinson", "mechanism", "Rasagiline", "information", "Introduction", "Key Features", "sterisonline", "sterispharma", "tolerability", "bradykinesia", "starting dose", "CALL/WHATSAPP", "MAO-B enzymes", "Initial Dosage", "Administration", "patient safety", "symptom relief", "motor symptoms", "primary action", "treatment plans", "adverse effects", "symptom control", "dosage strength", "Neuroprotection", "dopamine levels", "MAO-B Inhibition", "disease symptoms", "disease severity", "greater mobility", "oxidative stress", "MAO-B) inhibitor", "Maintenance doses", "targeted approach", "treatment efficacy", "neuronal integrity", "Dosage adjustments", "medical supervision", "disease progression", "healthcare providers", "Continued Monitoring", "therapeutic efficacy", "Rasagail 1.0 therapy", "potential side effects", "overall motor function", "functional independence", "Improved Motor Function", "individual patient needs", "flexible dosing regimens", "disease-modifying effects", "potent monoamine oxidase-B", "neuroprotective properties", "Ongoing clinical monitoring", "smoother motor coordination", "individual patient response", "optimal therapeutic benefits", "dopaminergic neurotransmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1888, "imageuri": "https://productimages.withfloats.com/actual/666ae69dc9162f54a1593ccc.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae69dc9162f54a1593ccc.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:31:22.172Z", "updatedon": "2024-06-26T07:19:57.74Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rasagail-1/1888", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RASAGAIL 1", "category": "NEUROLOGY RANGE", "tags": [ "RASAGAIL 1", "rasagiline 1 mg price", "rasagiline 1 mg uses", "rasagiline benefits", "rasagiline side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae5c5ca84cd189c25cbff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rasagail 0.5 ", "description": "Rasagail 0.5 \nRasagiline (0.5mg)\nIntroduction:\n\nRasagail 0.5 encapsulates the medicinal prowess of Rasagiline, a potent and selective monoamine oxidase-B (MAO-B) inhibitor used in the management of Parkinson's disease. With a dosage strength of 0.5mg, Rasagail 0.5 aims to optimize neurological function and enhance quality of life for individuals battling Parkinson's disease.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 0.5 exerts its therapeutic effects by selectively inhibiting MAO-B enzymes, thereby increasing dopamine levels in the brain's striatum. This mechanism helps alleviate motor symptoms and improve motor function in Parkinson's disease.\nNeuroprotective Properties:\n\nBeyond symptomatic relief, Rasagail 0.5 offers neuroprotective benefits by reducing oxidative stress, preventing neuronal damage, and potentially slowing disease progression in Parkinson's patients.\nEnhanced Dopaminergic Transmission:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 0.5 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and independence.\nAdjunctive Therapy:\n\nRasagail 0.5 can be used as monotherapy in early-stage Parkinson's disease or as an adjunct to levodopa/carbidopa in advanced stages, providing a comprehensive approach to symptom management.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 0.5 is 0.5mg once daily, taken orally with or without food. Dosage adjustments may be made based on individual patient response and tolerability.\nTitration and Maintenance:\nGradual titration may occur as directed by healthcare providers to achieve optimal therapeutic benefits while minimizing side effects. Maintenance doses are typically tailored to individual patient needs.\nContinued Monitoring:\nRegular clinical assessments and monitoring of Parkinson's disease symptoms, motor function, and potential adverse effects are essential components of Rasagail 0.5 therapy to ensure treatment efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/rasagail-0-5-133622", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "life", "EMAIL", "Order", "0.5mg", "brain", "safety", "tremors", "quality", "striatum", "rigidity", "patients", "carbidopa", "mechanism", "Rasagiline", "monotherapy", "information", "individuals", "Introduction", "sterisonline", "Key Features", "bradykinesia", "independence", "side effects", "tolerability", "sterispharma", "CALL/WHATSAPP", "MAO-B enzymes", "starting dose", "Administration", "Initial Dosage", "motor function", "motor symptoms", "dopamine levels", "dosage strength", "neuronal damage", "advanced stages", "MAO-B) inhibitor", "oxidative stress", "greater mobility", "MAO-B Inhibition", "disease symptoms", "Maintenance doses", "medicinal prowess", "Gradual titration", "Adjunctive Therapy", "symptom management", "Dosage adjustments", "treatment efficacy", "symptomatic relief", "therapeutic effects", "disease progression", "essential components", "healthcare providers", "Rasagail 0.5 therapy", "Continued Monitoring", "neurological function", "early-stage Parkinson", "comprehensive approach", "neuroprotective benefits", "individual patient needs", "potential adverse effects", "Neuroprotective Properties", "individual patient response", "smoother motor coordination", "optimal therapeutic benefits", "Regular clinical assessments", "selective monoamine oxidase-B", "dopaminergic neurotransmission", "Enhanced Dopaminergic Transmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1887, "imageuri": "https://productimages.withfloats.com/actual/666ae5c88c6c791fd3b65cab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae5c88c6c791fd3b65cab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:27:49.832Z", "updatedon": "2024-06-26T07:22:12.294Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rasagail-0-5-/1887", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rasagail 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "rasagiline side effects", "rasagiline benefits", "long-term side effects of rasagiline", "rasagiline uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66640616e69b8516f884e85d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BACLOFINE 25 ", "description": "BACLOFINE 25 \nBaclofen (25mg)\nBaclofine 25 contains Baclofen (25mg), a muscle relaxant used to alleviate symptoms associated with spasticity, a condition often seen in multiple sclerosis and spinal cord injuries. Baclofen acts on the central nervous system to reduce muscle tension and involuntary muscle spasms, enhancing comfort and mobility.\n\nThis medication is typically prescribed when muscle stiffness interferes significantly with daily activities, causing pain and limited movement. Baclofen can also be used in managing symptoms of muscle clenching and rigidity in various neurological disorders.\n\nWhile Baclofine 25 is effective in relieving muscle spasms, it should be used under strict medical supervision due to potential side effects like drowsiness, weakness, and dizziness. It's crucial to follow the dosage instructions provided by a healthcare professional to minimize risks and ensure effectiveness.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/baclofine-25-133759\n\n\n\n\n\n\n", "price": 239.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "25mg", "pain", "Email", "risks", "comfort", "Baclofen", "mobility", "WhatsApp", "symptoms", "weakness", "rigidity", "dizziness", "condition", "BACLOFINE", "drowsiness", "spasticity", "medication", "information", "sterispharma", "sterisonline", "effectiveness", "muscle tension", "muscle relaxant", "limited movement", "daily activities", "muscle clenching", "muscle stiffness", "multiple sclerosis", "dosage instructions", "spinal cord injuries", "potential side effects", "central nervous system", "healthcare professional", "involuntary muscle spasms", "strict medical supervision", "various neurological disorders" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1545, "imageuri": "https://productimages.withfloats.com/actual/667d1441ba7e6420d2a4fd10.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d1441ba7e6420d2a4fd10.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T07:19:50.582Z", "updatedon": "2024-06-28T10:49:42.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/baclofine-25-/1545", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BACLOFINE 25 ", "category": "GASTROLOGYRANGE", "tags": [ "", "baclofen 25 mg uses", "baclofen 25 mg side effects", "baclofen 25 mg uses", "baclofen 25 mg tablet uses in hindi", "BACLOFINE 25", "Baclofen 25 mg side effects", "How strong is baclofen 10 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d518ce6b4e65282a1dc798", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg", "description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)", "price": 238.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2181, "imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:26:22.554Z", "updatedon": "2025-09-25T10:26:22.554Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 400 CAP", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d2786bf4017fefeee0b981", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ketorolac tromethamine dispersible tablets 10 mg", "description": "KEYPROFEN DT is a fast-acting nonsteroidal anti-inflammatory drug (NSAID) used to relieve moderate pain and inflammation. Its dispersible tablet form ensures quick dissolution and faster pain relief, making it convenient for oral administration. Ideal for managing post-operative pain, musculoskeletal discomfort, and other short-term pain conditions.", "price": 166.0, "discountamount": 49.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2180, "imageuri": "https://productimages.withfloats.com/actual/68d2786fd0799a6bd13134e7.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d2786fd0799a6bd13134e7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-23T10:37:31.507Z", "updatedon": "2025-09-23T10:37:31.507Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ketorolac-tromethamine-dispersible-tablets-10-mg/2180", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "KEYPROFEN DT", "category": "GENERAL RANGE", "tags": [ "KEYPROFEN DT", "ketorolac tromethamine dispersible tablets 10 mg uses in hindi", "ketorolac tromethamine dispersible tablets 10 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }